Cefixime & Potassium Clavulanate Tablets – Zefral CV Tablets

Cefixime & Potassium Clavulanate Tablets – A Perfect Pair for Broad-Spectrum Protection And Strength to Combat Resistant Infections

Zefral CV Tablets: The Dual combination of Cefixime Trihydrate 200mg + Clavulanic Acid 125mg combines two potent formulations of Dry Syrup agent, which is used to treat various bacterial infections of the urinary tract, where Cefixime is a generation cephalosprin beta lactmase inhbhitor that work by inhibitingbacterial cell wall synthesis which binds to specific penicillin-binding proteins (PBPs) on the bacterial cell membrane, blocking the final stages of peptidoglycan synthesis and prevents the bacterial cell from maintaining its cell wall, causing structural weakness, leading to cell lysis and death. Clavulanic acid is a beta-lactamase inhibitor that helps protect Cefixime from being broken down by beta-lactamase enzymes produced by certain bacteria. It also works by enhancing the activity of Cefixime against bacteria, decreasing bacterial resistance.

Recommended By Specialists:
General Physicians: It is used to prefer the combination to treat the disease associated with upper and lower respiratory tract infections, UTIs
Pulmonologists: It is preferred for bronchitis, pneumonia, and other lower respiratory tract infections caused by resistant organisms.
Urologists: It is prefer to treat the disease associated for r skin and soft tissue infections

Key benefits of Cefixime & Potassium Clavulanate Tablets – Zefral CV Tablets:
Broad spectrum efficiency: The combination of Cefixime (a cephalosporin) and clavulanic acid (a beta-lactamase inhibitor)enhances the effectiveness against a wide range of bacteria, including resistant bacteria
Convenient Formulation: The Dry syrup formulation allows for easier storage and longer shelf life compared to the liquid formulation. It can be easily adjusted to different doses, and the syrup can be flavored to improve taste, making it more acceptable to children who have difficulty swallowing tablets or capsules.
Reduced side effects: The combination therapy provides effective infection control while reducing the risk of of adverse effect as Clavulanic Acid helps prevent the breakdown of Cefixime by resistant bacteria.

INDICATIONS:
Lower Respiratory Tract Infections
Recurrent Tonsillitis & Pharyngitis
Chronic or Recurrent UTIs
Otitis Media
Skin & Soft Tissue Infections